4.7 Article

Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 107, Issue 3, Pages 668-684

Publisher

ENDOCRINE SOC
DOI: 10.1210/clinem/dgab790

Keywords

autosomal dominant diabetes; monogenic diabetes; gene mutation; Krebs cycle; glucose homeostasis; insulin secretion

Funding

  1. Italian Diabetes Society (SID)
  2. NIH [R01DK55523, P30 DK036836]
  3. Italian Ministry of Health
  4. Italian Ministry of University and Research
  5. Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand [R016034011]
  6. Thailand Research Fund
  7. Office of the Higher Education Commission, Thailand [MRG6280107]
  8. NVIDIA corporation
  9. NIH Office of Research Infrastructure Programs [P40 OD010440]

Ask authors/readers for more resources

This study identified mutations in the MDH2 gene that are associated with familial forms of diabetes. These mutations affect the structure and function of the MDH2 protein. They increase the enzymatic activity of MDH2, leading to a decrease in the NAD+/NADH ratio and affecting insulin signaling and secretion. This study suggests that gain of function variants in the MDH2 gene may play a role in the etiology of familial forms of diabetes.
Context Genes causing familial forms of diabetes mellitus are only partially known. Objective We set out to identify the genetic cause of hyperglycemia in multigenerational families with an apparent autosomal dominant form of adult-onset diabetes not due to mutations in known monogenic diabetes genes. Methods Existing whole-exome sequencing (WES) data were used to identify exonic variants segregating with diabetes in 60 families from the United States and Italy. Functional studies were carried out in vitro (transduced MIN6-K8 cells) and in vivo (Caenorhabditis elegans) to assess the diabetogenic potential of 2 variants in the malate dehydrogenase 2 (MDH2) gene linked with hyperglycemia in 2 of the families. Results A very rare mutation (p.Arg52Cys) in MDH2 strongly segregated with hyperglycemia in 1 family from the United States. An infrequent MDH2 missense variant (p.Val160Met) also showed disease cosegregation in a family from Italy, although with reduced penetrance. In silico, both Arg52Cys and Val160Met were shown to affect MDH2 protein structure and function. In transfected HepG2 cells, both variants significantly increased MDH2 enzymatic activity, thereby decreasing the NAD(+)/NADH ratio-a change known to affect insulin signaling and secretion. Stable expression of human wild-type MDH2 in MIN6-K8 cell lines enhanced glucose- and GLP-1-stimulated insulin secretion. This effect was blunted by the Cys52 or Met160 substitutions. Nematodes carrying equivalent changes at the orthologous positions of the mdh-2 gene showed impaired glucose-stimulated insulin secretion. Conclusion Our findings suggest a central role of MDH2 in human glucose homeostasis and indicate that gain of function variants in this gene may be involved in the etiology of familial forms of diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available